Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 1/2 2Phase 4 1Phase 3 1Phase 1 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Wrist Fractures 1Triple Negative Breast Neoplasms 1Thyroid Diseases 1Stomach Neoplasms 1Portal Vein Tumor Thrombus 1Meningiomas of the Middle Cranial Fossa 1Hand Injuries 1Edema 1Dupuytren Contracture 1Disease 1Adenocarcinoma Of Esophagus 1

Interventions

Surgical Procedures, Operative 1Oxaliplatin 1Leucovorin 1Irinotecan 1Fluorouracil 1Cryotherapy 1Congresses as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Adenocarcinoma Of Esophagus × Surgical Procedures, Operative × Clear all
NCT02366819 2026-03-30

Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

University of Chicago

Phase 4 Suspended
36 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡